Insights

Innovative Age Reversal Turn Biotechnologies specializes in pioneering rejuvenation therapies that target multiple aging hallmarks, positioning them as a leader in anti-aging and regenerative medicine. This offers opportunities to collaborate with clinics and wellness centers interested in advanced longevity treatments.

Strategic Collaborations Recent licensing agreements with HanAll Biopharma for epigenetic reprogramming technologies indicate a focus on ophthalmic and otic therapies, suggesting potential partnership opportunities with pharmaceutical companies targeting age-related eye and ear conditions.

Emerging Therapies Turn's development of novel treatments for age-related diseases and its proprietary delivery platform eTurna provide avenues for sales engagement with biotech firms, research institutions, and healthcare providers seeking cutting-edge therapeutics.

Growth and Funding Although currently with modest revenue, Turn's active funding activities and recent hires in research and finance highlight potential scalability and investment opportunities, making them a viable partner for early-stage collaborations and funding initiatives.

Technological Expertise Leveraging mRNA technology for rejuvenation and disease treatment positions Turn at the forefront of biotech innovation, presenting opportunities to offer complementary services, technology licensing, or joint R&D projects with organizations aiming to develop advanced gene and cell therapies.

Turn Biotechnologies Tech Stack

Turn Biotechnologies uses 8 technology products and services including CIM Technologies, jQuery CDN, Open Graph, and more. Explore Turn Biotechnologies's tech stack below.

  • CIM Technologies
    Cad & Graphics
  • jQuery CDN
    Content Delivery Network
  • Open Graph
    Content Management System
  • Squarespace
    Content Management System
  • jQuery
    Javascript Libraries
  • SAP Maintenance, Repair, and Overhaul
    Operations
  • Google
    Search Engines
  • HSTS
    Security

Media & News

Turn Biotechnologies's Email Address Formats

Turn Biotechnologies uses at least 1 format(s):
Turn Biotechnologies Email FormatsExamplePercentage
First.Last@turn.bioJohn.Doe@turn.bio
49%
First.L@turn.bioJohn.D@turn.bio
1%
First.Last@turn.bioJohn.Doe@turn.bio
49%
First.L@turn.bioJohn.D@turn.bio
1%

Frequently Asked Questions

Where is Turn Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Turn Biotechnologies's main headquarters is located at 319 North Bernardo Ave, Mountain View, California 94043, US. The company has employees across 3 continents, including North AmericaAfricaEurope.

What is Turn Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Turn Biotechnologies's official website is turn.bio and has social profiles on LinkedInCrunchbase.

What is Turn Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Turn Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Turn Biotechnologies have currently?

Minus sign iconPlus sign icon
As of October 2025, Turn Biotechnologies has approximately 31 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Chief Executive Officer: A. K.Co-Founder & Chief Operating Officer: S. R.Associate Vice President: N.. Explore Turn Biotechnologies's employee directory with LeadIQ.

What industry does Turn Biotechnologies belong to?

Minus sign iconPlus sign icon
Turn Biotechnologies operates in the Biotechnology Research industry.

What technology does Turn Biotechnologies use?

Minus sign iconPlus sign icon
Turn Biotechnologies's tech stack includes CIM TechnologiesjQuery CDNOpen GraphSquarespacejQuerySAP Maintenance, Repair, and OverhaulGoogleHSTS.

What is Turn Biotechnologies's email format?

Minus sign iconPlus sign icon
Turn Biotechnologies's email format typically follows the pattern of First.Last@turn.bio. Find more Turn Biotechnologies email formats with LeadIQ.

When was Turn Biotechnologies founded?

Minus sign iconPlus sign icon
Turn Biotechnologies was founded in 2018.
Turn Biotechnologies

Turn Biotechnologies

Biotechnology ResearchUnited States11-50 Employees

Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body.

In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks.

Join us as we embark on the task to "turn back time."

Section iconCompany Overview

Headquarters
319 North Bernardo Ave, Mountain View, California 94043, US
Website
turn.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Turn Biotechnologies's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Turn Biotechnologies's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.